NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (LBRX), a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other ...
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the ...
Iloperidone, a second-generation antipsychotic used to treat schizophrenia, appears to be safe and effective in the treatment of bipolar mania, new research suggested. Results of the phase 3 ...
The bipolar depression market is anticipated to increase during the forecast period (2026--2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), ...
Valerie Taylor's research explores links between gut bacteria and bipolar disorder, testing faecal microbiota transplants as potential treatments for mental illness.
(RTTNews) - LB Pharmaceuticals Inc. (LBRX), a clinical-stage biopharmaceutical company, announced the initiation of a Phase 2 trial of investigational drug LB-102 in bipolar depression, dubbed ...
GH Research announced positive Phase 2a trial results for GH001 in postpartum and bipolar II depression, with high remission rates. GH Research PLC announced significant progress in its clinical ...
The bipolar spectrum includes baseline temperaments like hyperthymia, dysthymia, and cyclothymia, which can change how treatment targets are set. Key Takeaways ______________ What is “bipolar”? It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results